One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial

OBJECTIVE: To assess the balance between costs and effects of the sirolimus eluting stent in the treatment of single native de novo coronary lesions in the RAVEL (randomised study with the sirolimus eluting Bx Velocity balloon expandable stent in the treatment of patients with de novo native coronary artery lesions) study. DESIGN: Multicentre, double blind, randomised trial. SETTING: Percutaneous coronary intervention for single de novo coronary lesions. PATIENTS: 238 patients with stable or unstable angina. INTERVENTIONS: Randomisation to sirolimus eluting stent or bare stent implantation. MA... Mehr ...

Verfasser: Hout, B.A. (Ben) van
Lemos Neto, P.A. (Pedro)
Es, G.A. (Gerrit Anne) van
Lindeboom, W.K. (Wietze)
Morice, M-C. (Marie-Claude)
Brand, M.J.B.M. (Marcel) van den
Serruys, P.W.J.C. (Patrick)
Dokumenttyp: Artikel
Erscheinungsdatum: 2005
Schlagwörter: Coronary Angiography/economics / Coronary Restenosis/economics/prevention & control/radiography / Coronary Stenosis/economics/*therapy / Cost-Benefit Analysis / Disease-Free Survival / Double-Blind Method / Female / Humans / Immunosuppressive Agents/*administration & dosage/therapeutic use / Male / Metals / Netherlands / Research Support / Non-U.S. Gov't / Sirolimus/*administration & dosage/therapeutic use / Stents/*economics / Surface Properties
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26833122
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/8358